291 related articles for article (PubMed ID: 33182770)
1. Pygenic Acid A (PA) Sensitizes Metastatic Breast Cancer Cells to Anoikis and Inhibits Metastasis In Vivo.
Lim GE; Sung JY; Yu S; Kim Y; Shim J; Kim HJ; Cho ML; Lee JS; Kim YN
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182770
[TBL] [Abstract][Full Text] [Related]
2. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
3. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
4. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH
Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956
[TBL] [Abstract][Full Text] [Related]
7. Icariside I reduces breast cancer proliferation, apoptosis, invasion, and metastasis probably through inhibiting IL-6/STAT3 signaling pathway.
Hou M; Li H; He T; Hui S; Dai W; Hou X; Zhao J; Zhao J; Wen J; Kan W; Xiao X; Zhan X; Bai Z
J Pharm Pharmacol; 2024 May; 76(5):499-513. PubMed ID: 37971302
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
9. Demethylzeylasteral (T-96) inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways.
Li L; Ji Y; Fan J; Li F; Li Y; Wu M; Cheng H; Xu C
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):593-603. PubMed ID: 30729271
[TBL] [Abstract][Full Text] [Related]
10. V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.
Schempp CM; von Schwarzenberg K; Schreiner L; Kubisch R; Müller R; Wagner E; Vollmar AM
Mol Cancer Ther; 2014 Apr; 13(4):926-37. PubMed ID: 24482380
[TBL] [Abstract][Full Text] [Related]
11. Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.
Wang K; Zou P; Zhu X; Zhang T
Toxicol In Vitro; 2019 Dec; 61():104653. PubMed ID: 31525383
[TBL] [Abstract][Full Text] [Related]
12. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
Salaroglio IC; Gazzano E; Abdullrahman A; Mungo E; Castella B; Abd-Elrahman GEFA; Massaia M; Donadelli M; Rubinstein M; Riganti C; Kopecka J
J Exp Clin Cancer Res; 2018 Nov; 37(1):286. PubMed ID: 30482226
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
[TBL] [Abstract][Full Text] [Related]
14. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY
Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775
[TBL] [Abstract][Full Text] [Related]
15. Curcumol Suppresses Triple-negative Breast Cancer Metastasis by Attenuating Anoikis Resistance
Li CL; Huang CW; Ko CJ; Fang SY; Ou-Yang FU; Pan MR; Luo CW; Hou MF
Anticancer Res; 2020 Oct; 40(10):5529-5538. PubMed ID: 32988876
[TBL] [Abstract][Full Text] [Related]
16. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer.
Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564
[TBL] [Abstract][Full Text] [Related]
17. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
19. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
[TBL] [Abstract][Full Text] [Related]
20. Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy.
Zhang J; Yang F; Mei X; Yang R; Lu B; Wang Z; Ji L
Chem Biol Interact; 2022 Jan; 351():109739. PubMed ID: 34742683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]